Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials

Chronic obstructive pulmonary disease (COPD) is characterised by progressive airflow limitation and chronic inflammation. Predicting exacerbations of COPD, which contribute to disease progression, is important...

Source: Respiratory Research - September 17, 2020 Category: Respiratory Medicine Authors: Dave Singh, Jadwiga A. Wedzicha, Salman Siddiqui, Alberto de la Hoz, Wenqiong Xue, Helgo Magnussen, Marc Miravitlles, James D. Chalmers and Peter M. A. Calverley Tags: Research Source Type: research